For further product information contact PHARMA DYNAMICS Email info@pharmadynamics.co.za CUSTOMER CARE LINE +27 21 707 7000 www.pharmadynamics.co.za Benefits of Rosuvastatin: Jones PH, et al., reported 79 % to 92 % of patients achieved a LDL goal of < 3.0 mmol/L across the dose range. 1 Ridker PM, et al., reported a 65 % reduction in vascular events in patients achieving both LDL < 1.8 mmol/L and hsCRP < 2 mg/L. 2 CONVENIENTLY PACKED IN 30’s ROSUVASTAT I N 5 / 10 / 20 / 40 mg NEW INTRODUCING OUR ROSUVASTATIN RANGE CREVAS 5, 10, 20, 40 mg. Each tablet contains 5, 10, 20, 40 mg rosuvastatin respectively. S3 A46/7.5/0313, 0314, 0315, 0316. NAM NS2 21/7.5/0057, 0058, 0059, 0060. For full prescribing information, refer to the professional information approved by SAHPRA, 12 July 2022. 1) Jones PH, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial). The American Journal of Cardiology 2003;93:152-160. 2) Ridker PM, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. The Lancet 2009;373:1175-1182. CSA996/02/2023 STELLAR PERFORMER
RkJQdWJsaXNoZXIy NDIzNzc=